Salil Kallianpur
@salilkallianpur
July 1st, 2008 12:18
Pharmaceutical industry executive, avid reader and part-time blogger. Tweets are personal views, RTs aren't.
Salil Kallianpur
@salilkallianpur
July 1st, 2008 12:18
Pharmaceutical industry executive, avid reader and part-time blogger. Tweets are personal views, RTs aren't.
Feeds
515Following
0Followers
320Likes
0Top scripts
Overall User Sentiment
Our Sponsors
Our Sponsors
salilkallianpur
@salilkallianpur
June 9th, 2023 13:40
Increased competition, US gov measures to lower drug prices are leading to pricing pressure: Granules' Priyanka Chi… https://t.co/5w9toEYkaD
Increased competition, US gov measures to lower drug prices are leading to pricing pressure: Granules' Priyanka Chi… https://t.co/5w9toEYkaD
salilkallianpur
@salilkallianpur
June 9th, 2023 13:40
Increased competition, US gov measures to lower drug prices are leading to pricing pressure: Granules' Priyanka Chi… https://t.co/5w9toEYkaD
June 9th, 2023 13:40
Increased competition, US gov measures to lower drug prices are leading to pricing pressure: Granules' Priyanka Chi… https://t.co/5w9toEYkaD
salilkallianpur
@salilkallianpur
June 7th, 2023 09:33
Natco Pharma on the lookout for acquisition https://t.co/H6AniVQWfF
Natco Pharma on the lookout for acquisition https://t.co/H6AniVQWfF
salilkallianpur
@salilkallianpur
June 7th, 2023 09:33
Natco Pharma on the lookout for acquisition https://t.co/H6AniVQWfF
June 7th, 2023 09:33
Natco Pharma on the lookout for acquisition https://t.co/H6AniVQWfF
salilkallianpur
@salilkallianpur
June 7th, 2023 09:33
Indoco Remedies slumps 5% as US FDA slaps OAI status on Goa plant https://t.co/zpzEsWExAJ
Indoco Remedies slumps 5% as US FDA slaps OAI status on Goa plant https://t.co/zpzEsWExAJ
salilkallianpur
@salilkallianpur
June 7th, 2023 09:33
Indoco Remedies slumps 5% as US FDA slaps OAI status on Goa plant https://t.co/zpzEsWExAJ
June 7th, 2023 09:33
Indoco Remedies slumps 5% as US FDA slaps OAI status on Goa plant https://t.co/zpzEsWExAJ
salilkallianpur
@salilkallianpur
June 6th, 2023 07:58
How will Coherus' Humira biosimilar launch at sharp discount play out for Biocon? https://t.co/UNnd2t0KHZ
How will Coherus' Humira biosimilar launch at sharp discount play out for Biocon? https://t.co/UNnd2t0KHZ
salilkallianpur
@salilkallianpur
June 6th, 2023 07:58
How will Coherus' Humira biosimilar launch at sharp discount play out for Biocon? https://t.co/UNnd2t0KHZ
June 6th, 2023 07:58
How will Coherus' Humira biosimilar launch at sharp discount play out for Biocon? https://t.co/UNnd2t0KHZ
salilkallianpur
@salilkallianpur
June 6th, 2023 07:19
Aurobindo Pharma completes plant installation in China https://t.co/iK1bXBkBEg
Aurobindo Pharma completes plant installation in China https://t.co/iK1bXBkBEg
salilkallianpur
@salilkallianpur
June 6th, 2023 07:19
Aurobindo Pharma completes plant installation in China https://t.co/iK1bXBkBEg
June 6th, 2023 07:19
Aurobindo Pharma completes plant installation in China https://t.co/iK1bXBkBEg
salilkallianpur
@salilkallianpur
May 27th, 2023 07:05
Taro Pharma weighing offer from Sun Pharma to acquire company at $38 share https://t.co/bmMQ510zzE
Taro Pharma weighing offer from Sun Pharma to acquire company at $38 share https://t.co/bmMQ510zzE
salilkallianpur
@salilkallianpur
May 27th, 2023 07:05
Taro Pharma weighing offer from Sun Pharma to acquire company at $38 share https://t.co/bmMQ510zzE
May 27th, 2023 07:05
Taro Pharma weighing offer from Sun Pharma to acquire company at $38 share https://t.co/bmMQ510zzE
salilkallianpur
@salilkallianpur
May 22nd, 2023 19:05
Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore https://t.co/emQ1qpk1JR
Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore https://t.co/emQ1qpk1JR
salilkallianpur
@salilkallianpur
May 22nd, 2023 19:05
Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore https://t.co/emQ1qpk1JR
May 22nd, 2023 19:05
Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore https://t.co/emQ1qpk1JR
salilkallianpur
@salilkallianpur
May 19th, 2023 08:30
Quite something! | Cambridge University names building after Cipla chief Yusuf Hamied, first Indian to get the hono… https://t.co/eqM0ucCEIX
Quite something! | Cambridge University names building after Cipla chief Yusuf Hamied, first Indian to get the hono… https://t.co/eqM0ucCEIX
salilkallianpur
@salilkallianpur
May 19th, 2023 08:30
Quite something! | Cambridge University names building after Cipla chief Yusuf Hamied, first Indian to get the hono… https://t.co/eqM0ucCEIX
May 19th, 2023 08:30
Quite something! | Cambridge University names building after Cipla chief Yusuf Hamied, first Indian to get the hono… https://t.co/eqM0ucCEIX
salilkallianpur
@salilkallianpur
May 14th, 2023 19:07
Future of pharma company Hikal at risk due to warring promoters, warns independent advisory firm InGovern https://t.co/8qQtgs0DWC
Future of pharma company Hikal at risk due to warring promoters, warns independent advisory firm InGovern https://t.co/8qQtgs0DWC
salilkallianpur
@salilkallianpur
May 14th, 2023 19:07
Future of pharma company Hikal at risk due to warring promoters, warns independent advisory firm InGovern https://t.co/8qQtgs0DWC
May 14th, 2023 19:07
Future of pharma company Hikal at risk due to warring promoters, warns independent advisory firm InGovern https://t.co/8qQtgs0DWC
salilkallianpur
@salilkallianpur
May 10th, 2023 19:55
Vaccine maker Sanofi India to demerge consumer healthcare business https://t.co/ii7sZexptp
Vaccine maker Sanofi India to demerge consumer healthcare business https://t.co/ii7sZexptp
salilkallianpur
@salilkallianpur
May 10th, 2023 19:55
Vaccine maker Sanofi India to demerge consumer healthcare business https://t.co/ii7sZexptp
May 10th, 2023 19:55
Vaccine maker Sanofi India to demerge consumer healthcare business https://t.co/ii7sZexptp